Peer-influenced content. Sources you trust. No registration required. This is HCN.
Journal of Clinical Oncology
The conclusion from the study presented in the Journal of Clinical Oncology: “While VTC added to five-drug interval compressed chemotherapy did not improve survival, these outcomes represent the best survival estimates to date for patients with previously untreated nonmetastatic Ewing sarcoma.”
Hematology/Oncology December 21st 2021